C P Re
Product Images NDC 81445-0007

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for C P Re (NDC 81445-0007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coexleaders Co.,ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

CPRe is a drug that contains Qystershell powder and is intended to aid in the treatment of cardiovascular disease. It is important to check the product's ingredients for allergies before taking it, and to handle the product package with care. The product should be kept away from direct sunlight, high temperatures, humidity, and freezing temperatures. The recommended dose is two capsules twice a day. Inactive ingredients include sweet potato powder, chitosan powder, and black soybean powder. Read the directions and warnings before use, and consult a doctor if any abnormal symptoms occur.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.